文献速递运动医学关节外科

术前非阿片类镇痛减少关节镜术后阿片类药物消耗:随机对照试验的系统综述与荟萃分析

Preoperative Nonopioid Analgesia Reduces Postoperative Opioid Consumption After Arthroscopic Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Sports Med · 2026-01-13

该系统综述与荟萃分析纳入22项随机对照试验,评估术前非阿片类药物对关节镜术后疼痛管理的影响。结果显示,任何术前药物类型在术后24小时口服吗啡当量消耗平均减少4.3 mg(95%CI -6.1至-2.5,P<.001,I2=96%),COX-2抑制剂和加巴喷丁分别减少4.2 mg和6.3 mg。尽管差异有统计学意义,但减少幅度和VAS疼痛评分改善可能不具有临床意义,且文献异质性高。

要点

  • 术前非阿片类药物可显著减少关节镜术后24小时阿片消耗,但幅度可能不具临床意义。
  • COX-2抑制剂和加巴喷丁是研究较多的术前药物,分别减少4.2 mg和6.3 mg口服吗啡当量。
  • 当前证据异质性高,需高质量前瞻性研究确定最佳疼痛管理方案。

核心结论

  • 术前使用非阿片类药物(特别是COX-2抑制剂和加巴喷丁)与关节镜术后阿片消耗的统计学显著减少相关。
  • 尽管有统计学显著性,观察到的阿片消耗和VAS疼痛评分降低可能不代表临床意义的改善。
  • 现有文献异质性高,需要高质量前瞻性研究更准确评估最佳疼痛管理方法。

研究设计与样本

  • 系统综述与荟萃分析,证据等级1。
  • 检索PubMed、MEDLINE、Embase三个数据库,检索日期为2024年12月12日。
  • 纳入研究为调查术前干预对关节镜术后疼痛管理效果的随机对照试验,共纳入22项研究。
  • 提取数据包括患者人口统计学、手术类型、镇痛方案(类型、剂量、时机)、不良反应、术后阿片消耗和疼痛评分。
  • 术后阿片消耗标准化并转换为口服吗啡当量,疼痛评分采用视觉模拟量表(VAS)评估。

主要发现

  • 任何术前药物类型在术后24小时口服吗啡当量消耗的总体合并平均减少为4.3 mg(95%CI -6.1至-2.5;P<.001;I2=96%)。
  • 术前COX-2抑制剂给药在术后24小时口服吗啡当量消耗的合并平均减少为4.2 mg(95%CI -7.9至-0.5;P=.03;I2=93%)。
  • 术前加巴喷丁给药在术后24小时口服吗啡当量消耗的合并平均减少为6.3 mg(95%CI -9.6至-3.0;P<.001;I2=90%)。
  • 术前COX-2抑制剂还带来统计学显著的VAS疼痛减少0.3 cm(95%CI -0.5至-0.02;P=.04)。
  • 接受前交叉韧带重建的患者术后阿片消耗高于一般膝关节或肩关节镜手术患者。

临床怎么用

  • 骨科医生可考虑在关节镜手术前使用非阿片类药物(如COX-2抑制剂或加巴喷丁)以减少术后阿片消耗。
  • 应认识到现有证据显示的效果量可能不具临床意义,需结合患者具体情况个体化决策。

局限性

  • 现有文献异质性高(I2值达96%),可能影响结果可靠性。
  • 观察到的阿片消耗和VAS疼痛评分降低可能不具临床意义。
  • 需要高质量前瞻性研究以更准确评估最佳疼痛管理方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Orthopaedic surgeons frequently overprescribe opioids after arthroscopic surgery. Previous research has shown reductions in postoperative opioid consumption and pain scores with multimodal nonopioid analgesics. However, the clinical effect of preoperative analgesic strategies has not been fully uncovered. PURPOSE: To assess the outcomes of arthroscopic surgery associated with preoperative treatment with nonopioid medications. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 1. METHODS: Three online databases (PubMed, MEDLINE, Embase) were searched on December 12, 2024, to identify randomized controlled trials investigating the effect of preoperative intervention on pain management following arthroscopic surgery. Extracted data included patient demographics, surgery type, analgesic protocols (ie, type, dosing, timing), adverse effects, postoperative opioid consumption, and pain scores. Postoperative opioid consumption was standardized and converted to oral morphine equivalents. Pain scores were assessed using the visual analog scale (VAS). Weighted means and meta-analyses were conducted to compare postoperative outcomes. Subgroup analyses were performed by analgesic class (COX-2 inhibitors, gabapentin) and surgery type. The quality of studies was assessed with the Risk of Bias 2 tool. RESULTS: A total of 22 studies were included in this review. The overall pooled mean reduction in postoperative opioid consumption with any preoperative medication type was 4.3 mg of oral morphine equivalents (95% CI, -6.1 to -2.5; P < .001; I2 = 96%) at 24 hours. The pooled mean reduction associated with preoperative COX-2 administration and gabapentin was 4.2 mg (95% CI, -7.9 to -0.5; P = .03; I2 = 93%) and 6.3 mg (95% CI, -9.6 to -3.0; P < .001; I2 = 90%) at 24 hours, respectively. Preoperative COX-2 inhibitors also yielded a statistically significant VAS pain reduction of 0.3 cm (95% CI, -0.5 to -0.02; P = .04). Patients undergoing anterior cruciate ligament reconstruction had higher postoperative opioid consumption as compared with general knee or shoulder arthroscopies. CONCLUSION: This systematic review demonstrated that preoperative treatment with nonopioid medications, particularly COX-2 inhibitors and gabapentin, is associated with statistically significant reductions in postoperative opioid consumption after arthroscopic surgery. Despite statistically significant findings, observed reductions in postoperative opioid consumption and VAS pain scores may not represent clinically meaningful improvements. The current available literature is highly heterogeneous, indicating the need for high-quality prospective studies to more accurately assess optimal approaches to pain management.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Dworsky-Fried J, Fowler R, Vivekanantha P, et al. Preoperative Nonopioid Analgesia Reduces Postoperative Opioid Consumption After Arthroscopic Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2026. PMID: 41527448. doi:10.1177/03635465251396164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。